-
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Consensus Recommendation of "Buy" by Analysts
Source: Buzz FX / 17 Feb 2025 02:35:12 America/New_York
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat February 17, 2025 Share Link copied to clipboard. Spyre Therapeutics, Inc. ( NASDAQ:SYRE - Get Free Report ) has received a con
Read more...